Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Stopping aripiprazole can reverse its side effect of hair loss.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

The gene KAP22-1 affects wool yield and fiber shape in sheep.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Acyzol could help treat conditions caused by zinc deficiency.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.